Smart SCALEs With Bioimpedance Analysis for Treatment Guidance in Decompensated Heart Failure (SCALE HF)
Status
Conditions
Treatments
Details and patient eligibility
About
In this trial the measurement of whole body water will be compared to the standard method of measuring the body weight as treatment guidance in patients with decompensated heart failure. The Seca mBCA 515 [medical Body Composition Analyser] will be used to quantify the whole body water by using bioelectrical impedance analysis.
Full description
Investigators will include 153 participants hospitalized in the University Hospital in Basel. Daily measurements of whole body water and body weight will be performed in each person until diuretic treatment is stopped or the patient is discharged from hospital, respectively.
Primary endpoint is the correlation between reduction of whole body water (in kg) and reduction of body weight (in kg) in patients with decompensated heart failure receiving forced diuretic treatment (max. deviation +/- 1kg).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- able to give informed consent
- hospitalization because of decompensated heart failure treated with forced diuresis
- able to stand on the scale without help from others and able to hold handrails with both hands
Exclusion criteria
- refusal to share personal data
- implantable electronic device (e.g. Pacemaker, etc.)
- condition that does not allow skin contact of soles of feet and scale or hands with handrail (leg prosthesis, wounds, bandage, etc.)
Trial design
Primary purpose
Allocation
Interventional model
Masking
153 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal